News and ViewsRecent Price Performance and Market Comparison
Metropolis Healthcare’s stock has been under pressure over the past week, falling by 2.46%, which notably exceeds the Sensex’s modest decline of 0.40% during the same period. The one-month performance also shows a similar pattern, with the stock retreating 2.73% compared to the benchmark’s 0.23% dip. Year-to-date, the stock has declined by 9.06%, contrasting sharply with the Sensex’s robust 8.12% gain. Over the last year, the stock has underperformed significantly, dropping 11.7% while the Sensex rose by 5.36%. However, the longer-term three-year returns remain positive at 44.75%, slightly outperforming the Sensex’s 37.73%, though the five-year returns are almost flat at 0.09%, far behind the benchmark’s 79.90% growth.
